Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human APP Abeta Recombinant Antibody(Solanezumab)

Product Information
Catalog Number YR1197
Product Name Anti-Human APP Abeta Recombinant Antibody(Solanezumab)
Molecular Name Solanezumab
Alias Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab
CAS Number 955085-14-0
Target APP Abeta[Homo sapiens]
Isotype IgG1 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Applications WB, FuncS, IF, Neut, ELISA, FCM, IP
Buffer PBS, pH7.5
Background Solanezumab (proposed INN, LY2062430[1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector[2] for patients with Alzheimer's disease.[3][4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.[5]
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.